Page last updated: 2024-10-31

monodansylcadaverine and Neurodegenerative Diseases

monodansylcadaverine has been researched along with Neurodegenerative Diseases in 1 studies

monodansylcadaverine: inhibits cross linkage of fibrin
monodansylcadaverine : A sulfonamide obtained by formal condensation of the sulfo group of 5-(dimethylamino)naphthalene-1-sulfonic acid with one of the amino groups of cadaverine.

Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Igarashi, S1
Koide, R1
Shimohata, T1
Yamada, M1
Hayashi, Y1
Takano, H1
Date, H1
Oyake, M1
Sato, T1
Sato, A1
Egawa, S1
Ikeuchi, T1
Tanaka, H1
Nakano, R1
Tanaka, K1
Hozumi, I1
Inuzuka, T1
Takahashi, H1
Tsuji, S1

Other Studies

1 other study available for monodansylcadaverine and Neurodegenerative Diseases

ArticleYear
Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch.
    Nature genetics, 1998, Volume: 18, Issue:2

    Topics: Animals; Apoptosis; Base Sequence; Cadaverine; COS Cells; Cystamine; DNA Primers; Enzyme Inhibitors;

1998